Loading
A phase 3 trial in lung cancer, run by Ottawa Hospital Research Institute, now recruiting.
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III is a phase 3, randomised interventional study registered as NCT04871412 by Ottawa Hospital Research Institute, with a registry enrolment figure of 20 participants, started 2022-04-04 and due to reach its primary completion in 2028-12-01. Interventions recorded: Vitamin D3 Drops; Coriolus Versicolor; Trident SAP 66:33 Lemon; Probiotic Pro12; Provitalix Pure Whey Protein; Theracurmin 2X; Green Tea Extract; Nutrition Recommendations; Physical Activity Recommendations; Psychological Recommendations. Conditions listed: Lung Cancer; Gastric Cancer; Esophageal Cancer. Primary outcome: Participant Recruitment Rates; Participant Retention Rates; Cross-over and contamination in the control arm - Supplement usage. Lung eligibility wording from the registry: "• Adults eligible for complete resection of lung, gastric or esophageal cancer". Sites: Canada. No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Lung cancer (all types) and the tag lung-deep-dive.